Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:BNXT)

Bionxt Solutions Announces Odf Cladribine Update and Financing

Accesswire 1 hour ago

BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps

Accesswire March 18, 2024

BioNxt Reports Successful Results From ODF Cladribine PK Study

Accesswire March 13, 2024

BioNxt completes study on its oral MS treatment

Jonathon Brown March 4, 2024

BioNxt Reports Completion of ODF Cladribine PK Study

Accesswire March 4, 2024

BioNxt Solutions Finalizes Agreement

Accesswire February 16, 2024

BioNxt reveals results from multiple sclerosis treatment study

Jocelyn Aspa February 7, 2024

BioNxt Reports Successful Results From ODF Cladribine Toxicity Study

Accesswire February 7, 2024

BIONXT SOLUTIONS ANNOUNCES CLOSING OF FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT

Accesswire January 29, 2024
View More News ››

Opinion & Analysis (CSE:BNXT)

XPhyto: Buyouts, Biosensors and a Booming Business

Stockhouse Editorial August 4, 2021

XPhyto: Proof of Concept for Mescalin Synthesis

Stockhouse Editorial June 10, 2021

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

Stockhouse Editorial June 3, 2021

A Life Sciences Project Accelerator Kicks into High Gear

Stockhouse Editorial May 11, 2021

XPhyto: Why Rapid PCR Testing is Here to Stay

Stockhouse Editorial April 23, 2021

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

Stockhouse Editorial April 6, 2021
View More Opinion ››

Bullboard Posts (CSE:BNXT)

Toasted 101

We know what direction this stock is headed. Lot of potential back in the early covid days but now not so sure. GLTA and perhaps some...
Franman184 - July 25, 2022

XPhyto Announces Offering of Units of the Company

XPhyto Therapeutics Announces Offering of Units of the Company 2022-07-22 13:30 ET - News Release XPHY Close 2022-07-22 C$ 0.485 ...
toasted101 - July 22, 2022

RE:RE:Hello XPHY - ANYBODY OUT THERE!

Wow this stock is hurting !! 
RDtrade - April 28, 2022

XPhyto, Biosensors Market and Product Developments

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / April 11, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE...
Betteryear2 - April 11, 2022

RE:Hello XPHY - ANYBODY OUT THERE!

Does anyone have any other information out there Not sure what happened to the PCR side of things ?
RDtrade - April 6, 2022

Hello XPHY - ANYBODY OUT THERE!

Anybody out thier selling? Comeon man give us some sales annoucements. 
Franman184 - March 18, 2022
View more Bullboard ››

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »